Intrathecal medicines
30 results
Applied filters
Fluorescein: informing intrathecal risk assessment
8 July 2025Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Understanding risks with intrathecal administration
17 June 2025The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.
Managing an intrathecal chemotherapy service
13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.
Choosing an injectable medicine for intrathecal administration
13 June 2025The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk
Iohexol: informing intrathecal risk assessment
20 May 2025Iohexol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Clonidine: informing intrathecal risk assessment
13 May 2025Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Baclofen: informing intrathecal risk assessment
7 May 2025Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Shelf lives of aseptically prepared medicines in NRFit syringes
23 December 2024Provision of intrathecal and epidural injections in NRFit syringes may involve extrapolation of stability data from luer lock systems
Bupivacaine: informing intrathecal risk assessment
3 April 2024Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Trastuzumab: informing intrathecal risk assessment
19 February 2024Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration